Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications. 2010

Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples, via de Crecchio 7, 80138, Naples, Italy.

The production of industrially relevant microbial polysaccharides has recently gained much interest. The capsular polysaccharide of Escherichia coli K4 is almost identical to chondroitin, a commercially valuable biopolymer that is so far obtained from animal tissues entailing complex and expensive extraction procedures. In the present study, the production of capsular polysaccharide by E. coli K4 was investigated taking into consideration a potential industrial application. Strain physiology was first characterized in shake flask experiments to determine the optimal culture conditions for the growth of the microorganism and correlate it to polysaccharide production. Results show that the concentration of carbon source greatly affects polysaccharide production, while the complex nitrogen source is mainly responsible for the build up of biomass. Small-scale batch processes were performed to further evaluate the effect of the initial carbon source concentration and of growth temperatures on polysaccharide production, finally leading to the establishment of the medium to use in following fermentation experiments on a bigger scale. The fed-batch strategy next developed on a 2-L reactor resulted in a maximum cell density of 56 g(cww)/L and a titre of capsular polysaccharide equal to 1.4 g/L, approximately ten- and fivefold higher than results obtained in shake flask and 2-L batch experiments, respectively. The release kinetics of K4 polysaccharide into the medium were also explored to gain insight into the mechanisms underlying a complex aspect of the strain physiology.

UI MeSH Term Description Entries
D007218 Industrial Microbiology The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms. Microbiology, Industrial
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D016667 Bacterial Capsules An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides. Bacterial Capsule,Capsule, Bacterial,Capsules, Bacterial
D019149 Bioreactors Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen. Fermentors,Bioreactor,Fermentor

Related Publications

Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
June 2005, Molecular biotechnology,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
July 2014, Biotechnology letters,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
August 2015, Biotechnology journal,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
May 2013, Microbial cell factories,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
October 1988, European journal of biochemistry,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
January 1990, FEMS microbiology letters,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
January 1988, Reviews of infectious diseases,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
January 2013, Biotechnology progress,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
February 2004, Electrophoresis,
Donatella Cimini, and Odile Francesca Restaino, and Angela Catapano, and Mario De Rosa, and Chiara Schiraldi
August 1999, Biochemical Society transactions,
Copied contents to your clipboard!